1、White PaperTransforming Weight Management Trials Through Digital Health Technology TAPAN K.RAVAL,Director,Medical,Connected Devices,IQVIA.Table of contentsIntroduction 3Since 2020,there has been an explosion in research.4What are digital health technologies(dhts)?5Potential benefits of digital healt

2、h technology in clinical trials 6DHT improves outcomes in clinical trials 6Applying digital health technology to obesity clinical trials 6Regulatory considerations 7Physical device considerations 7Study conduct and identification considerations onsite and off 7Experience in implementing DHTs is esse

3、ntial to success 8Taking a holistic approach in obesity trial design is critical to success 8References 10About the author is a global pandemicIntroduction 25%of the worlds population will be obese by 20351,2 1 out of 8 adult deaths are driven by high BMI(25 kg/m2)1 10%of all adult deaths(non-commun

4、icable disease-NCD)are attributable to high BMI1With the obesity epidemic cutting across all demographic groups including age,gender,disease conditions,socioeconomic status,and nationality,it is critical that clinical trials include sufficient diversity of participants to mirror the target patient p

5、opulation.Included in the participant identification and enrollment process attention should also be paid to medication adherence which is essential for successful outcomes.Assessing a proper assortment of individuals in trials will help clinicians have confidence that the intervention has been test

6、ed and proven in the people they see in their practices.Further,the ability of the physician to tell the patient that the recommended intervention was in fact researched in people just like them will aid in discussions around maintenance therapy.The Food and Drug Administration has recently issued r